Product Information
Registration Status: ActiveSIN15888P
BOOSTRIX POLIO SUSPENSION FOR INJECTION is approved to be sold in Singapore with effective from 2020-02-20. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN15888P.
This product contains Diphtheria Toxoid 2.5 Lf/ 0.5 ml - not less than 2 IU,Filamentous Hemagglutinin (Fha) 8 mcg/0.5ml,Inactivated Polio Virus Type 1 40 DU/0.5 ml,Inactivated Polio Virus Type 2 8 DU/0.5 ml,Inactivated Polio Virus Type 3 32 DU/0.5 ml,Pertactin (Prn) 2.5 mcg/0.5 ml,Pertussis Toxoid (Pt) 8 mcg/0.5 ml, and Tetanus Toxoid 5.0 Lf/0.5ml - not less than 20 IU in the form of INJECTION, SUSPENSION. It is approved for INTRAMUSCULAR use.
This product is manufactured by GlaxoSmithKline Biologicals SAS in FRANCE.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection. It is used for active immunization of children 7 years of age or older, and adults, for prevention of tetanus. The toxoid in the Clostridium tetani culture is grown and detoxified followed by purification via ammonium sulfate filtration and precipation.
Active Ingredient/Synonyms
Tetanus toxoid | Tetanus toxoid adsorbed | tetanus toxoid vaccine, inactivated | Clostridium tetani toxoid antigen (formaldehyde inactivated) |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.